| Asset | Company | Stage | Mechanism | Lead Indication | Ownership |
|---|---|---|---|---|---|
| YORVIPATH_TransCon_PTH | ASND | Approved | Once-daily TransCon prodrug releasing PTH | ||
| QW_TransCon_PTH | ASND | Preclinical | Once-weekly TransCon prodrug designed to match YORVIPATH exposure over entire week |